Ngari

Ngari is a prefecture in the westernmost part of the Tibet Autonomous Region of China. It is known for its rugged landscape, which includes the northern part of the Himalayas, and is home to several important historical and cultural sites, including the ruins of the ancient Guge kingdom and the sacred Mount Kailash and Lake Manasarovar.

Geography

Ngari is located in the western part of the Tibet Autonomous Region, bordering Xinjiang to the north and India, Nepal, and Bhutan to the west and south. The region is characterized by its high altitude and rugged terrain, with an average elevation of over 4,500 meters. The northern part of the Himalayas runs through Ngari, and the region is also home to several large lakes, including Lake Manasarovar and Lake Rakshastal.

History

The history of Ngari is closely tied to the ancient Guge kingdom, which ruled the region from the 10th to the 17th centuries. The ruins of the Guge kingdom, located in the town of Zanda, are a major tourist attraction in Ngari. The region was incorporated into the Tibet Autonomous Region in 1965.

Culture

Ngari is known for its rich cultural heritage, which includes several important Buddhist sites. Mount Kailash, located in Ngari, is considered a sacred site by several religions, including Buddhism, Hinduism, and Jainism. Lake Manasarovar, also located in Ngari, is another important religious site, and is believed to be the source of four major rivers in Asia.

Economy

The economy of Ngari is primarily based on agriculture and animal husbandry, with barley, wheat, and rapeseed being the main crops. The region is also known for its production of cashmere wool. In recent years, tourism has become an increasingly important part of the economy, with visitors drawn to Ngari's historical sites and natural beauty.

See also

• Tibet Autonomous Region
• Guge
• Mount Kailash
• Lake Manasarovar

Ngari Resources
Need Help Finding a Doctor? WikiMD's DocFinder can help find general and specialist physicians.	Latest articles Most recent articles Ongoing trials.